Access Bio Inc

950130

Company Profile

  • Business description

    Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

  • Contact

    65 Clyde Road
    Suite A
    SomersetNJ08873
    USA

    T: +1 732 873-4040

    E: [email protected]

    https://www.accessbio.net

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    79

Stocks News & Analysis

stocks

Navigating the ASX dividend landscape in 2026

Dividend yields are well below the 10-year average. Here’s how to navigate lower yields in 2026.
stocks

Meta stock has struggled amid AI spending concerns. Is it a buy?

Meta stock has lost ground as investors raise concern over capital expenditures and risky AI strategies.
stocks

Netflix Earnings: Strong, as expected; 2026 guidance confirms decelerating growth

We think Netflix stock is moderately overvalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,172.5012.400.14%
CAC 408,166.1396.961.20%
DAX 4024,877.52316.541.29%
Dow JONES (US)49,072.24583.651.20%
FTSE 10010,209.9271.830.71%
HKSE26,597.4912.430.05%
NASDAQ23,224.82270.501.18%
Nikkei 22553,688.89914.251.73%
NZX 50 Index13,556.8717.06-0.13%
S&P 5006,873.7776.911.13%
S&P/ASX 2008,848.7012.800.14%
SSE Composite Index4,122.585.640.14%

Market Movers